Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Revvity Inc (RVTY)

Revvity Inc (RVTY)
42.95 x 2 147.70 x 1
Pre-market by (Cboe BZX)
107.36 -0.02 (-0.02%) 03/26/25 [NYSE]
42.95 x 2 147.70 x 1
Pre-market 107.36 unch (unch) 19:00 ET
Quote Overview for Wed, Mar 26th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
105.90
Day High
108.17
Open 106.99
Previous Close 107.38 107.38
Volume 806,100 806,100
Avg Vol 1,091,315 1,091,315
Stochastic %K 15.57% 15.57%
Weighted Alpha -3.04 -3.04
5-Day Change -2.56 (-2.33%) -2.56 (-2.33%)
52-Week Range 97.32 - 129.50 97.32 - 129.50
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,901,385
  • Shares Outstanding, K 120,147
  • Annual Sales, $ 2,755 M
  • Annual Income, $ 270,390 K
  • EBIT $ 347 M
  • EBITDA $ 781 M
  • 60-Month Beta 1.06
  • Price/Sales 4.74
  • Price/Cash Flow 12.75
  • Price/Book 1.72

Options Overview Details

View History
  • Implied Volatility 33.96% ( +3.39%)
  • Historical Volatility 29.19%
  • IV Percentile 75%
  • IV Rank 51.42%
  • IV High 45.24% on 11/01/24
  • IV Low 22.01% on 05/10/24
  • Put/Call Vol Ratio 2.70
  • Today's Volume 37
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.73
  • Today's Open Interest 409
  • Open Int (30-Day) 861

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.95
  • Number of Estimates 7
  • High Estimate 0.97
  • Low Estimate 0.95
  • Prior Year 0.98
  • Growth Rate Est. (year over year) -3.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
105.45 +1.81%
on 03/21/25
Period Open: 115.11
120.39 -10.82%
on 03/10/25
-7.75 (-6.73%)
since 02/26/25
3-Month
105.45 +1.81%
on 03/21/25
Period Open: 112.50
128.29 -16.31%
on 01/30/25
-5.14 (-4.57%)
since 12/26/24
52-Week
97.32 +10.32%
on 04/18/24
Period Open: 103.42
129.50 -17.10%
on 11/06/24
+3.94 (+3.81%)
since 03/26/24

Most Recent Stories

More News
Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks

TECH : 59.38 (-1.00%)
TMO : 513.67 (-0.13%)
WAT : 367.79 (-0.20%)
AVTR : 16.28 (-0.43%)
RVTY : 107.36 (-0.02%)
3 Reasons to Sell RVTY and 1 Stock to Buy Instead

3 Reasons to Sell RVTY and 1 Stock to Buy Instead

CRWD : 371.41 (-3.52%)
RVTY : 107.36 (-0.02%)
Do Options Traders Know Something About Revvity (RVTY) Stock We Don't?

Investors in Revvity, Inc. RVTY need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 21, 2025 $80 Call had some of the highest implied volatility...

RVTY : 107.36 (-0.02%)
Are Wall Street Analysts Bullish on Revvity Stock?

Revvity has lagged behind the broader market this year, and Wall Street analysts maintain a cautiously optimistic outlook on its future potential.

XLV : 144.74 (-0.36%)
BCS : 16.06 (-1.17%)
$SPX : 5,712.20 (-1.12%)
RVTY : 107.36 (-0.02%)
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations

Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations

RVTY : 107.36 (-0.02%)
Revvity’s Q4 2024 Earnings: What to Expect

Revvity will release its fourth-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth.

XLV : 144.74 (-0.36%)
XLV : 144.74 (-0.36%)
$SPX : 5,712.20 (-1.12%)
RVTY : 107.36 (-0.02%)
RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

Revvity, Inc. RVTY announced the receipt of the FDA’s 510(k) clearance for EUROIMMUN’s automated chemiluminescence-based immunoassay (ChLIA) test for free testosterone. Per management, it is currently...

BSX : 102.34 (-0.72%)
RMD : 221.88 (+0.27%)
CAH : 133.98 (+0.93%)
RVTY : 107.36 (-0.02%)
Is Revvity Stock Underperforming the S&P 500?

Revvity has substantially lagged behind the S&P 500 over the past year, yet analysts remain bullish on the stock’s prospects.

$SPX : 5,712.20 (-1.12%)
IDXX : 417.71 (+0.01%)
RVTY : 107.36 (-0.02%)
What Are Wall Street Analysts' Target Price for Revvity Stock?

Revvity has underperformed the broader market this year, but Wall Street analysts remain somewhat optimistic about the stock's future prospects.

XLV : 144.74 (-0.36%)
$SPX : 5,712.20 (-1.12%)
RVTY : 107.36 (-0.02%)
Stocks Settle Mostly Higher on President-Elect Trump’s Pro-Growth Promises

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.05%. Stocks on Monday...

MSTR : 329.31 (-3.66%)
AVGO : 179.27 (-4.78%)
SPNS : 27.37 (+0.29%)
ADI : 210.53 (-1.43%)
$IUXX : 19,916.99 (-1.83%)
COIN : 193.95 (-5.03%)
ZNM25 : 110-085 (-0.27%)
MNDY : 264.47 (-4.64%)
TSLA : 272.06 (-5.58%)
GFS : 38.75 (-0.67%)
LRCX : 76.14 (-1.97%)
$DOWI : 42,454.79 (-0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software,...

See More

Key Turning Points

3rd Resistance Point 110.66
2nd Resistance Point 109.41
1st Resistance Point 108.39
Last Price 107.36
1st Support Level 106.12
2nd Support Level 104.87
3rd Support Level 103.85

See More

52-Week High 129.50
Fibonacci 61.8% 117.21
Fibonacci 50% 113.41
Fibonacci 38.2% 109.61
Last Price 107.36
52-Week Low 97.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies